GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 80 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,472 | -82.0% | 34,577 | -79.6% | 0.00% | -100.0% |
| Q2 2023 | $330,539 | -36.6% | 169,507 | -9.6% | 0.00% | -50.0% |
| Q1 2023 | $521,042 | +1646.4% | 187,425 | +2067.3% | 0.00% | – |
| Q4 2022 | $29,836 | +6.6% | 8,648 | -20.0% | 0.00% | – |
| Q3 2022 | $28,000 | -65.9% | 10,811 | -68.2% | 0.00% | – |
| Q2 2022 | $82,000 | -50.0% | 34,041 | -14.4% | 0.00% | – |
| Q1 2022 | $164,000 | +25.2% | 39,754 | +288.9% | 0.00% | – |
| Q4 2021 | $131,000 | +1537.5% | 10,222 | +1019.6% | 0.00% | – |
| Q2 2021 | $8,000 | – | 913 | +3411.5% | 0.00% | – |
| Q1 2021 | $0 | – | 26 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
| Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
| Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
| Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
| Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
| Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
| SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
| Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
| Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |